Concepedia

Publication | Open Access

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

DOIFull Paper Access

111

Citations

53

References

2023

Year

Jason J. Luke, Manish R. Patel, George R. Blumenschein, Erika Hamilton, Bartosz Chmielowski, Susanna V. Ulahannan, Roisín M. Connolly, Cesar A. Santa‐Maria, Jie Wang, Shakeela Bahadur,
Nature Medicine

References

YearCitations

Page 1